AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
Financial Statements
- Click here to download Abbvie Inc's Income Statement
- Click here to download Abbvie Inc's Balance Sheet
- Click here to download Abbvie Inc's Statement of Cash Flows
Key Info
- Industry: Pharmaceutical Preparation Manufacturing
- Sector: Manufacturing
- CEO Name: Richard Gonzalez
Key Statistics
- Stock Price: $120.78
- Dividend Yield: 4.1000000000000005%
- Market Capitalization: $213,068,353,893
- Shares Outstanding: 1,767,175,532
- Number of Employees: 2,020
- Trailing 12-Month EPS: $3.71
- Trailing 12-Month DPS: $5.0
- Payout Ratio: 134.8%
Important Dates
- Next Earnings Date: 2021-10-29
- Next Ex-Dividend Date: 2021-07-14
Price Trends
- Current Stock Price: $120.78
- 52-week high: $121.4
- 52-week low: $76.4
- 200-day moving average: $111.3
- 50-day moving average: $117.3
Performance
- 1-Month Price Return: 3.7%
- 3-Month Price Return: 7.7%
- 6-Month Price Return: 14.5%
- 1-Year Price Return: 34.4%
- 2-Year Price Return: 103.3%
- 5-Year Price Return: 135.8%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast